EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieKlinische Studie (Phase II)Open Access

Image-based Re-evaluation of the JCOG0911 Study Focusing on Tumor Volume and Survival, Disease Progression Diagnosis, and Radiomic Prognostication for Newly Diagnosed Glioblastoma

Manabu Kinoshita, Yasutaka Fushimi, Tomohiko Masumoto, Keita Sasaki, Tetsuya Sekita, Atsushi Natsume, Toshihiko Wakabashi, Takashi Komori, Shunsuke Tsuzuki, Yoshihiro Muragaki, Kazuya Motomura, Ryuta Saito und 28 weitere

Magnetic Resonance in Medical Sciences · 2025

DOI: 10.2463/mrms.mp.2024-0103 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Magnetic Resonance in Medical Sciences, 2025. Verfasst von Manabu Kinoshita und 39 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Asahikawa Medical University, Asahikawa, Hokkaido, Japan. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms, Magnetic Resonance Imaging. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Cancer Center Research and Development Fund, Health and Labour Sciences Research Grants, Ministry of Health, Labor and Welfare, Japan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To re-evaluate images recovered from JCOG0911, a randomized phase 2 trial for newly diagnosed glioblastoma (nGBM) conducted by the Japan Clinical Oncology Group (JCOG) Brain Tumor Study Group. METHODS: The correlation between tumor volumes and survival was evaluated, followed by progression-free survival (PFS) analysis by independent central review based on Response Assessment in Neuro-Oncology (RANO) criteria using MRI recovered from 118 nGBM patients enrolled in the JCOG0911 trial. A radiomic analysis was also performed to identify radiomic features predictive of nGBM prognosis. RESULTS: The distribution of the Gd-enhancing and T2-weighted image/fluid attenuated inversion recovery-high intensity lesions mainly occupied white matter. JCOG0911 consisted of more subjects with right-sided lesions. The median extent of resection of the Gd-enhancing lesions was 99%. The overall survival showed a nonsignificant negative trend with postoperative Gd-enhancing lesion volume (P = 0.22), with the hazard ratio increasing in parallel with its volume. The median PFS after registration was 302 and 308 days for local Response Evaluation Criteria in Solid Tumors (RECIST)-based and central RANO-based diagnoses. However, an apparent discrepancy was observed between the two in the early phase, presumably due to the misdiagnosis of pseudoprogression by local RECIST-based diagnosis. Radiomic analysis identified 28 radiomic features predictive of nGBM prognosis, 5 of which were those previously identified in a separate cohort. The constructed radiomics-based prognostic model stratified the cohort into high- and low-risk groups (P = 0.028). CONCLUSION: Novel analytical methods that could be incorporated into future clinical trials were successfully tested. RANO and RECIST may not differ in progression calls if pseudoprogression is appropriately handled.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaBrain NeoplasmsMagnetic Resonance ImagingHumansDisease ProgressionMaleFemaleMiddle AgedPrognosisTumor BurdenAgedAdultJapanProgression-Free SurvivalBrainRadiomics

Stichwörter der Autor:innen

RANORECISTglioblastomaprogression-free survivalradiomics

Autor:innen und Institutionen

  • Department of Neurosurgery, Asahikawa Medical University, Asahikawa, Hokkaido, Japan.
  • Department of Diagnostic Imaging and Nuclear Medicine, Kyoto University Graduate School of Medicine, Kyoto, Kyoto, Japan.
  • Department of Diagnostic Radiology, Toranomon Hospital, Tokyo, Japan.
  • JCOG Data Center/Operations Office, National Cancer Center Hospital, Tokyo, Japan.
  • The Institute of Innovation for Future Society, Nagoya University, Nagoya, Aichi, Japan.
  • Department of Neurosurgery, Nagoya Garden Clinic, Nagoya, Aichi, Japan.

Förderung

  • National Cancer Center Research and Development Fund
  • Health and Labour Sciences Research Grants
  • Ministry of Health, Labor and Welfare, Japan

Zitieren

APA

Kinoshita, M., Fushimi, Y., Masumoto, T., Sasaki, K., Sekita, T., Natsume, A., Wakabashi, T., Komori, T., Tsuzuki, S., Muragaki, Y., Motomura, K., Saito, R., Sato, K., Beppu, T., Takahashi, M., Kuroda, J. I., Sonoda, Y., Kobayashi, K., Mishima, K., …, & Members of Japan Clinical Oncology Group Brain Tumor Study Group (JCOG-BTSG) (2025). Image-based Re-evaluation of the JCOG0911 Study Focusing on Tumor Volume and Survival, Disease Progression Diagnosis, and Radiomic Prognostication for Newly Diagnosed Glioblastoma. Magnetic Resonance in Medical Sciences. https://doi.org/10.2463/mrms.mp.2024-0103

Vancouver

Kinoshita M, Fushimi Y, Masumoto T, Sasaki K, Sekita T, Natsume A, et al. Image-based Re-evaluation of the JCOG0911 Study Focusing on Tumor Volume and Survival, Disease Progression Diagnosis, and Radiomic Prognostication for Newly Diagnosed Glioblastoma. Magnetic Resonance in Medical Sciences. 2025. doi:10.2463/mrms.mp.2024-0103

BibTeX
@article{Kinoshita2025,
  author = {Kinoshita, Manabu and Fushimi, Yasutaka and Masumoto, Tomohiko and Sasaki, Keita and Sekita, Tetsuya and Natsume, Atsushi and Wakabashi, Toshihiko and Komori, Takashi and Tsuzuki, Shunsuke and Muragaki, Yoshihiro and Motomura, Kazuya and Saito, Ryuta and Sato, Kenichi and Beppu, Takaaki and Takahashi, Masamichi and Kuroda, Jun-Ichiro and Sonoda, Yukihiko and Kobayashi, Keiichi and Mishima, Kazuhiko and Mitsuya, Koichi and Yamasaki, Fumiyuki and Inoue, Akihiro and Matsutani, Tomoo and Nakamura, Hideo and Yamaguchi, Shigeru and Ishikawa, Eiichi and Nakaya, Masato and Tanaka, Shota and Ujifuku, Kenta and Uchida, Hiroyuki and Kanamori, Masayuki and Otani, Ryohei and Kijima, Noriyuki and Nishida, Namiko and Yoshino, Atsuo and Mineharu, Yohei and Arakawa, Yoshiki and Fukuda, Haruhiko and Narita, Yoshitaka and Members of Japan Clinical Oncology Group Brain Tumor Study Group (JCOG-BTSG), Members of Japan Clinical Oncology Group Brain Tumor Study Group (JCOG-BTSG)},
  title = {Image-based Re-evaluation of the JCOG0911 Study Focusing on Tumor Volume and Survival, Disease Progression Diagnosis, and Radiomic Prognostication for Newly Diagnosed Glioblastoma},
  journal = {Magnetic Resonance in Medical Sciences},
  year = {2025},
  doi = {10.2463/mrms.mp.2024-0103}
}
Kostenlos starten →